FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

427147004: Atosiban acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2007. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2662713015 Atosiban acetate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2674700014 Atosiban acetate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atosiban acetate Is a Atosiban false Inferred relationship Existential restriction modifier
Atosiban acetate Has disposition Peptide hormone receptor antagonist true Inferred relationship Existential restriction modifier
Atosiban acetate Is a Substance with peptide hormone receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Atosiban acetate Is a Peptide true Inferred relationship Existential restriction modifier
Atosiban acetate Is modification of Atosiban true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely atosiban (as atosiban acetate) 37.5 milligram/5 milliliter conventional release solution for infusion vial Has precise active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier 1
Product containing precisely atosiban (as atosiban acetate) 6.75 milligram/0.9 milliliter conventional release solution for injection vial Has precise active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier 1
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has precise active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier 1
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier 1
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier 1
Atosiban 6.75mg/0.9ml solution for injection pre-filled syringes Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection pre-filled syringes (Accord Healthcare Ltd) 1 pre-filled disposable injection Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection pre-filled syringes (Accord Healthcare Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Stragen UK Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Stragen UK Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Stragen UK Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Stragen UK Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 7.5mg/mL injection solution 0.9mL vial Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 7.5mg/mL infusion concentrate 5mL vial Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml solution for injection vials 1 vial Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) 1 vial Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials 1 vial Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 6.75mg/0.9ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 6.75mg/0.9ml solution for injection vials (Ferring Pharmaceuticals Ltd) 1 vial Has active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml solution for injection vials 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 7.5mg/mL infusion concentrate 5mL vial Has specific active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 6.75mg/0.9ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 7.5mg/mL injection solution 0.9mL vial Has specific active ingredient False Atosiban acetate Inferred relationship Existential restriction modifier
Tractocile 6.75mg/0.9ml solution for injection vials (Ferring Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Sun Pharmaceuticals UK Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Sun Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection ampoules Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection ampoules (Bowmed Ibisqus Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Bowmed Ibisqus Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection ampoules (Bowmed Ibisqus Ltd) 1 ampoule Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Bowmed Ibisqus Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection ampoules 1 ampoule Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml solution for infusion vials Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Accord Healthcare Ltd) Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial Has specific active ingredient True Atosiban acetate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start